Request Deal Involvement

Omega Funds and TCGX led a $207.5m Series C round in Aviceda Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Cooley

legal advisors

Cooley

Leerink Partners

financial advisors

Leerink Partners

Mintz Levin

legal advisors

Mintz Levin

Elephant Head Communications

pr advisors

Elephant Head Communications

Foley & Lardner

legal advisors

Foley & Lardner

or

Principals

OMEGA FUNDS

bidder

OMEGA FUNDS

LONGITUDE CAPITAL MANAGEMENT CO LLC

bidder

LONGITUDE CAPITAL MANAGEMENT CO LLC

DIGITALIS VENTURES

bidder

DIGITALIS VENTURES

ENAVATE SCIENCES

bidder

ENAVATE SCIENCES

AVICEDA THERAPEUTICS

target

AVICEDA THERAPEUTICS

JEITO CAPITAL

bidder

JEITO CAPITAL

TCGX

bidder

TCGX

BLUE OWL HEALTHCARE OPPORTUNITIES (EX-COWEN HEALTHCARE INVESTMENTS)

bidder

BLUE OWL HEALTHCARE OPPORTUNITIES (EX-COWEN HEALTHCARE INVESTMENTS)

MARSHALL WACE

bidder

MARSHALL WACE

ORBIMED ADVISORS LLC

bidder

ORBIMED ADVISORS LLC

CATALIO CAPITAL MANAGEMENT

bidder

CATALIO CAPITAL MANAGEMENT

LOGOS CAPITAL

bidder

LOGOS CAPITAL

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite